Oncolytics Biotech

🇨🇦Canada
Ownership
-
Employees
26
Market Cap
$74.3M
Website
Introduction

Oncolytics Biotech, Inc. engages in the development of immuno-oncolytic virus for the treatment of solid tumors and hematological malignancies. It offers a non-pathogenic, properietary isolate of the reovirus that induce selective tumor lysis, and promotes an inflamed tumor phenotype through innate and adaptive immune responses. The company was founded by Matthew C. Coffey and Bradley George Thompson on April 2, 1998 and is headquartered in Calgary, Canada.

Phase 2 Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Head and Neck Carcinoma

First Posted Date
2008-09-16
Last Posted Date
2014-11-04
Lead Sponsor
Oncolytics Biotech
Target Recruit Count
14
Registration Number
NCT00753038
Locations
🇺🇸

Cancer Therapy and Research Center at UTHSCSA, San Antonio, Texas, United States

🇺🇸

Montefiore Medical Center, Bronx, New York, United States

Safety and Efficacy Study of REOLYSIN® in the Treatment of Recurrent Malignant Gliomas

Phase 1
Completed
Conditions
First Posted Date
2007-09-12
Last Posted Date
2014-10-02
Lead Sponsor
Oncolytics Biotech
Target Recruit Count
18
Registration Number
NCT00528684
Locations
🇺🇸

Cedars-Sinai Medical Center, Los Angeles, California, United States

🇺🇸

University of Alabama at Birmingham, Birmingham, Alabama, United States

🇺🇸

The Ohio State University Medical Center and Arthur G. James Cancer Hospital and Richard J. Solove Research Center, Columbus, Ohio, United States

Safety and Efficacy Study of REOLYSIN® in the Treatment of Bone and Soft Tissue Sarcomas Metastatic to the Lung

First Posted Date
2007-07-18
Last Posted Date
2014-10-02
Lead Sponsor
Oncolytics Biotech
Target Recruit Count
53
Registration Number
NCT00503295
Locations
🇺🇸

Mayo Clinic, Rochester, Minnesota, United States

🇺🇸

Institute of Drug Development, Cancer Therapy Research Center, San Antonio, Texas, United States

🇺🇸

University of Michigan Medical School, Ann Arbor, Michigan, United States

and more 1 locations
© Copyright 2024. All Rights Reserved by MedPath